calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,015 phase readout · 2,181 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,015 phase readout · 2,181 8k filing · 2,000 device pma
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: INNOGENIX. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL
Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: SWAB. Route: TOPICAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION